Herein, we describe the use of a novel multiplug flow control technique for the curative
transarterial embolisation of cerebrovascular malformations using liquid embolic agents …

Endovascular embolization of brain arteriovenous malformations (AVMs) has improved with
liquid occlusive agents, but flow-related and anatomic restrictions limit endovascular …

OBJECTIVE: Effective transarterial embolization of a dural arteriovenous fistula or pial
arteriovenous malformation (AVM) requires penetration of a durable occlusive agent into the …

Background Arteriovenous malformations (AVMs) are vascular lesions that may be treated
by an endovascular approach using liquid embolic agents but the control of the liquid …

Background and Purpose Liquid embolic agents (LEAs) are the determinant tool for
successful embolization of cranial arteriovenous shunts. There are few currently available …

Embolization of arteriovenous malformations (AVMs) has developed over the last four
decades from an experimental treatment reported by Lussenhop and Spence in 1960 (1), to …

Background Transvenous embolization (TVE) is an emerging technique for the
endovascular treatment of cerebral arteriovenous malformations (AVMs). The aim of this …

✓ Endovascular therapy for arteriovenous malformations (AVMs) remains a relatively new
approach. Beginning in the 1960s with the use of flow-directed techniques for selective …

Liquid embolization of brain arteriovenous malformation using novel detachable tip micro
catheter: a technical report - PMC Back to Top Skip to main content NIH NLM Logo Access …

Due to the risk of cerebral hemorrhage, and its related morbidity–mortality, brain
arteriovenous malformations (bAVMs) are a rare and potentially life-threatening disease …